Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

SILO

SILO Pharma Inc

May 22 • 04:00PM ET

0.3910

+0.0150 3.99 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: TNXP LIXT PALI BCDA SABS

| Held by: PSIL VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.50	Insider Own	1.69%	Shs Outstand	16.27M	Perf Week	-2.32%
Market Cap	6.36M	Forward P/E	-	EPS next Y	-	Insider Trans	1.85%	Shs Float	15.99M	Perf Month	-17.44%
Enterprise Value	0.09M	PEG	-	EPS next Q	-	Inst Own	6.49%	Short Float	4.83%	Perf Quarter	39.05%
Income	-4.84M	P/S	90.86	EPS this Y	-	Inst Trans	-1.35%	Short Ratio	0.16	Perf Half Y	-1.01%
Sales	0.07M	P/B	1.12	EPS next Y	-	ROA	-74.99%	Short Interest	0.77M	Perf YTD	15.00%
Book/sh	0.35	P/C	1.01	EPS next 5Y	-	ROE	-99.94%	52W High	1.01 -61.29%	Perf Year	-8.58%
Cash/sh	0.39	P/FCF	-	EPS past 3/5Y	33.45% 26.52%	ROIC	-85.24%	52W Low	0.22 76.92%	Perf 3Y	-81.64%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	0.00% -	Gross Margin	-1244.34%	Volatility	11.27% 8.94%	Perf 5Y	-97.00%
Dividend TTM	-	EV/Sales	1.29	EPS Y/Y TTM	56.28%	Oper. Margin	-6631.16%	ATR (14)	0.04	Perf 10Y	-99.22%
Dividend Ex-Date	-	Quick Ratio	9.65	Sales Y/Y TTM	0.00%	Profit Margin	-6717.40%	RSI (14)	45.23	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	9.65	EPS Q/Q	47.74%	SMA20	-5.29%	Beta	0.74	Target Price	10.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	0.00%	SMA50	-5.75%	Rel Volume	0.05	Prev Close	0.38
Employees	3	LT Debt/Eq	0.00	Earnings	-	SMA200	-17.38%	Avg Volume	4.82M	Price	0.39
IPO	May 13, 2014	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	219,407	Change	3.99%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)